Last updated: 11/07/2018 00:44:48
A Phase I Study of Topotecan HCl Administered on a Daily Times Five Schedule with a Single Infusion of Cisplatin every Three Weeks to Patients with Advanced Non-small Cell Lung Carcinoma.
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Phase I Study of Topotecan HCl Administered on a Daily Times Five Schedule with a Single Infusion of Cisplatin every Three Weeks to Patients with Advanced Non-small Cell Lung Carcinoma.
Trial description: A Phase I Study of Topotecan HCl Administered on a Daily Times Five Schedule with a Single Infusion of Cisplatin every Three Weeks to Patients with Advanced Non-small Cell Lung Carcinoma.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Raymond E, Burris HA, Rowinsky EK, Eckardt JR, Rodriguez G, Smith L, Weiss G, Von Hoff DD. Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinoma. Ann Oncol. 1997;8(10):1003-1008.
Topotecan in combination with cisplatin in patients with previously untreated non-small-cell lung carcinoma. a phase i study. Raymond, E, Burris, H A, Rowinsky, E K, Eckardt, J R, Rodriguez, G, Smith, L, Weiss, G, and Von Hoff, D D 10th National Cancer Institute and European Organisation for Research and Treatment of Cancer Symposium on New Drugs in Cancer Therapy 6/16/1998 Amsterdam; Netherlands
Medical condition
Lung Cancer, Non-Small Cell
Product
topotecan
Collaborators
Not applicable
Study date(s)
June 1992 to August 1994
Type
Not applicable
Phase
1
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1994-24-08
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website